• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Envoy Medical, Inc. - Class A Common Stock (NQ:COCH)

    0.6897 -0.0060 (-0.86%)
    Streaming Delayed Price Updated: 9:30 AM EST, Jan 5, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 8,978
    Open 0.6897
    Bid (Size) 0.6711 (1,000)
    Ask (Size) 0.6900 (100)
    Prev. Close 0.6957
    Today's Range 0.6897 - 0.6900
    52wk Range 0.6400 - 1.910
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Envoy Medical Reaches Enrollment Milestone in Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear Implant
    White Bear Lake, Minnesota--(Newsfile Corp. - December 18, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"),... 
    Via Newsfile
    News headline image
    Envoy Medical Secures New Australian Patent for Cochlear Implant Innovation Aimed at Enhancing Input Signal-to-Noise Ratio
    White Bear Lake, Minnesota--(Newsfile Corp. - December 16, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"),... 
    Via Newsfile
    Topics Intellectual Property

    Performance

    YTD
    -0.9%
    -0.9%
    1 Month
    -18.1%
    -18.1%
    3 Month
    -14.5%
    -14.5%
    6 Month
    -53.4%
    -53.4%
    1 Year
    -55.8%
    -55.8%

    More News

    Read More
    News headline image
    Envoy Medical Completes First Set of Activations in Final Stage of Pivotal Clinical Study for its First-Of-Its-Kind Fully Implanted Acclaim(R) Cochlear Implant
    Via Newsfile
    News headline image
    Envoy Medical to Host Fireside Chat with CEO Brent Lucas and the First Acclaim(R) Cochlear Implant Patient
    Via Newsfile
    News headline image
    Envoy Medical Announces the Grant of Its 40th U.S. Patent
    Via Newsfile
    Topics Intellectual Property
    News headline image
    Envoy Medical Secures New U.S. Patent for Innovative Cochlear Implant System Featuring a Removable Earplug Sensor and an Implanted Battery
    Via Newsfile
    Topics Intellectual Property
    News headline image
    Envoy Medical Achieves Six-Month Milestone with First 10 Patients in Acclaim(R) Cochlear Implant Clinical Trial
    Via Newsfile
    Topics Intellectual Property
    News headline image
    Envoy Medical Reports Third Quarter 2025 Financial and Operational Results
    Via Newsfile
    Topics Intellectual Property
    News headline image
    Envoy Medical Announces First Three Patients Enrolled in Final Stage of Acclaim(R) Cochlear Implant Pivotal Clinical Trial
    Via Newsfile
    News headline image
    AI & Technology Virtual Investor Conference: Presentations Now Available for Online Viewing
    From Virtual Investor Conferences
    Via GlobeNewswire
    News headline image
    Envoy Medical Marks Three-Year Anniversary of First Patient Receiving Its Breakthrough Fully Implanted Cochlear Implant
    Via Newsfile
    News headline image
    Envoy Medical Receives Positive Listing Determination from NASDAQ
    Via Newsfile
    News headline image
    Envoy Medical to Present at the Virtual Technology Investor Conference on October 28th
    From Virtual Investor Conferences; Envoy Medical, Inc.
    Via GlobeNewswire
    News headline image
    AI & Technology Virtual Investor Conference Agenda Announced for October 28th
    From Virtual Investor Conferences
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Thursday's After-Market Session ↗
    Via Benzinga
    News headline image
    Envoy Medical Announces Closing of Up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
    Via Newsfile
    Topics Regulatory Compliance
    News headline image
    Keep an eye on the top gainers and losers in Wednesday's session. ↗
    Via Chartmill
    News headline image
    Dow Jumps Over 100 Points; US Crude Oil Inventories Increase ↗
    Via Benzinga
    Topics Stocks
    News headline image
    12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
    Via Benzinga
    News headline image
    Unusual volume stocks are being observed in Wednesday's session. ↗
    Via Chartmill
    News headline image
    Top movers in Wednesday's session ↗
    Via Chartmill
    News headline image
    Traders are paying attention to the gapping stocks in Wednesday's session. ↗
    Via Chartmill
    News headline image
    Nasdaq Gains 150 Points; US Mortgage Applications Decline ↗
    Via Benzinga
    News headline image
    These stocks that are showing activity before the opening bell on Wednesday. ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
    Via Benzinga

    Frequently Asked Questions

    Is Envoy Medical, Inc. - Class A Common Stock publicly traded?
    Yes, Envoy Medical, Inc. - Class A Common Stock is publicly traded.
    What exchange does Envoy Medical, Inc. - Class A Common Stock trade on?
    Envoy Medical, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Envoy Medical, Inc. - Class A Common Stock?
    The ticker symbol for Envoy Medical, Inc. - Class A Common Stock is COCH on the Nasdaq Stock Market
    What is the current price of Envoy Medical, Inc. - Class A Common Stock?
    The current price of Envoy Medical, Inc. - Class A Common Stock is 0.6897
    When was Envoy Medical, Inc. - Class A Common Stock last traded?
    The last trade of Envoy Medical, Inc. - Class A Common Stock was at 01/05/26 09:30 AM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.